FDA Inspection
Kansas City Oncology Program IRBKansas City Oncology Program IRB – FDA Inspection, Jan 26, 2012
Record Details
This FDA Inspection record concerns Kansas City Oncology Program IRB, with an inspection on January 26, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 26, 2012
- Product Type
- Drugs
View Company Profile
ID · 4321be95-9813-41c7-8208-b814c4260a12
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 765489
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 56.115(a)(4)Copies of IRB/CI correspondence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kansas City Oncology Program IRB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Kansas City Oncology Program IRB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.